Cargando…

Comparing Highly Efficacious Antimalarial Drugs

Colin Sutherland discusses a Policy Forum article that explores the design and standardization of pre-licensure phase III antimalarial treatment trials.

Detalles Bibliográficos
Autor principal:	Sutherland, Colin J
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586357/ https://www.ncbi.nlm.nih.gov/pubmed/19018659 http://dx.doi.org/10.1371/journal.pmed.0050228

Ejemplares similares

Marine Microbiome as a Source of Antimalarials
por: McCarthy, Peter J., et al.
Publicado: (2019)

Natural products are the treasure pool for antimalarial agents
por: Zhou, Bin, et al.
Publicado: (2022)

Host-directed therapy, an untapped opportunity for antimalarial intervention
por: Wei, Ling, et al.
Publicado: (2021)

Artemisinin Combination Therapy: A Good Antimalarial, but Is the Dose Right?
por: Garner, Paul
Publicado: (2013)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

The assessment of antimalarial drug efficacy in-vivo
por: White, Nicholas J.
Publicado: (2022)

Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries
por: Groger, Mirjam, et al.
Publicado: (2023)

A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens
por: Sutherland, Colin
Publicado: (2007)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria
por: Agomo, Chimere Obiora, et al.
Publicado: (2016)

The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957
por: Miguel-Blanco, Celia, et al.
Publicado: (2021)

How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions?
por: Sutherland, Colin J, et al.
Publicado: (2007)

Antimalarial efficacy and toxicological assessment of medicinal plant ingredients of Prabchompoothaweep remedy as a candidate for antimalarial drug development
por: Chaniad, Prapaporn, et al.
Publicado: (2023)

Modifications of Antiepileptic Drugs for Improved Tolerability and Efficacy
por: Landmark, Cecilie Johannessen, et al.
Publicado: (2008)

The efficacy of antimalarial drugs in the therapy of selected forms of cicatricial alopecia
por: Zbiciak-Nylec, Martyna A., et al.
Publicado: (2021)

Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents
por: van Schalkwyk, Donelly A, et al.
Publicado: (2017)

Estimated Under-Five Deaths Associated with Poor-Quality Antimalarials in Sub-Saharan Africa
por: Renschler, John P., et al.
Publicado: (2015)

Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes
por: Gomes, Ana Rita, et al.
Publicado: (2017)

The threat of antimalarial drug resistance
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2016)

CYP2C8 and antimalaria drug efficacy
por: Gil, JP, et al.
Publicado: (2007)

Ethics and Antimalarial Drug Resistance
por: Cheah, Phaik Yeong, et al.
Publicado: (2020)

Comparative efficacy of surgical approaches to disease modification in Parkinson disease
por: Rahimpour, Shervin, et al.
Publicado: (2022)

Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya
por: Okombo, John, et al.
Publicado: (2014)

Microphysiological Systems (“Organs‐on‐Chips”) for Drug Efficacy and Toxicity Testing
por: Low, LA, et al.
Publicado: (2017)

Machine learning approaches to predict drug efficacy and toxicity in oncology
por: Badwan, Bara A., et al.
Publicado: (2023)

Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors
por: Urbán, Patricia, et al.
Publicado: (2011)

Daily rhythms of both host and parasite affect antimalarial drug efficacy
por: Owolabi, Alíz T Y, et al.
Publicado: (2021)

Antimalarial drug resistance: An overview
por: Antony, Hiasindh Ashmi, et al.
Publicado: (2016)

Antimalarial drug and renal toxicity
por: Wiwanitkit, Viroj
Publicado: (2015)

Herbicidal properties of antimalarial drugs
por: Corral, Maxime G., et al.
Publicado: (2017)

World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
por: Bacon, David J, et al.
Publicado: (2007)

Drug resistance genomics of the antimalarial drug artemisinin
por: Winzeler, Elizabeth A, et al.
Publicado: (2014)

High-yielding continuous-flow synthesis of antimalarial drug hydroxychloroquine
por: Yu, Eric, et al.
Publicado: (2018)

World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria
por: Plowe, Christopher V, et al.
Publicado: (2007)

Trends in Antimalarial Drug Use in Africa
por: Flegg, Jennifer A., et al.
Publicado: (2013)

Antimalarial drug discovery: progress and approaches
por: Siqueira-Neto, Jair L, et al.
Publicado: (2023)

Efficacy of Eosin B as a New Antimalarial Drug in a Murine Model
por: Zamani, Zahra, et al.
Publicado: (2012)

Evaluating antimalarial efficacy in single-armed and comparative drug trials using competing risk survival analysis: a simulation study
por: Dahal, Prabin, et al.
Publicado: (2019)

New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2020)

Regulatory Solutions to the Problem of High Generic Drug Costs
por: Luo, Jing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lahklr0maf0k6svhlc7d93t6o9